Beyond the GLP-1RA weight loss ceiling
On 21 May 21, 2026, Eli Lilly’s retatrutide achieved a historic first; as of June 2026, it is the only…
obesity
-
-
Signal: Wegovy cuts cardiovascular risk by 20% for heart disease patients
Novo Nordisk’s blockbuster weight-loss drug Wegovy may reduce the risk of heart attack before the weight loss effects take place,…
-
Research suggests childhood obesity major risk factor for hip disease
New research has revealed that childhood obesity is causing growing number of adolescents to develop the Slipped Capital Femoral Epiphysis…
